Levocetirizine Dihydrochloride Tablet
Product Images NDC 69367-238

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 69367-238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levocetirizine 01)

Chemical structure of Levocetirizine Dihydrochloride, illustrating its molecular components including chloro-substituted phenyl rings, a piperazine ring, and carboxylic acid, labeled with .2HCl indicating its dihydrochloride salt form.*

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Label for Levocetirizine Dihydrochloride Tablets, USP 5 mg oral tablets, packaged in a container of 90 tablets. The label includes NDC 69367-238-09 and specifies prescription use only (Rx only). Manufactured by ScieGen Pharmaceuticals, Inc. for Westminster Pharmaceuticals, LLC. Storage instructions and dosage directions are partially visible. The label features the Westminster Pharmaceuticals logo and a note indicating no varnish on one section.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.